Durable radiologic and clinical disease stability beyond PSA progression in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA).
Diletta Bianchini
No relevant relationships to disclose
Shahneen Kaur Sandhu
No relevant relationships to disclose
Amy Mulick Cassidy
No relevant relationships to disclose
Andrea Zivi
No relevant relationships to disclose
Janusz Mezynski
No relevant relationships to disclose
Deborah Mukherji
No relevant relationships to disclose
Carmel Jo Pezaro
No relevant relationships to disclose
Alison Helen Reid
No relevant relationships to disclose
Nikhil Babu Oommen
No relevant relationships to disclose
David Olmos
No relevant relationships to disclose
Aurelius Gabriel Omlin
No relevant relationships to disclose
Ajit Sarvadikar
No relevant relationships to disclose
Emilda Thompson
No relevant relationships to disclose
Joanne Hunt
No relevant relationships to disclose
Elizabeth Sheridan
No relevant relationships to disclose
Gerhardt Attard
Consultant or Advisory Role - Janssen-Cilag; Millennium; Veridex
Honoraria - Ipsen; Janssen-Cilag; Sanofi
Research Funding - AstraZeneca
Johann Sebastian De Bono
Employment or Leadership Position - ICR
Consultant or Advisory Role - Janssen Pharmaceutical
Honoraria - Janssen Pharmaceutical